Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo. (2025). American Journal of Life Science and Innovation, 4(1), 27-35. https://doi.org/10.54536/ajlsi.v4i1.3268